Neuraworx Medical Technologies Inc.

EXCELSIOR, MN · Founded 2021 · Medtech · Private

Wearable device that augments cerebrovascular vasomotion to enhance glymphatic brain clearance

Claim this profile

Follows are private to you and power your alerts

Updated · neuraworx.com

Sector
Medtech
Headquarters
EXCELSIOR, MN
Founded
2021
Latest Form D
$25K, Jul 2024
Total capital
$25K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$25K
1 Form D · last Jul 2024
28 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
4 pending

Capital timeline

2024FEDERAL ↑EQUITY ↓Cumulative $25K1st Form D$25K
2024FEDERAL ↑EQUITY ↓Cumulative $25K1st Form D$25K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$25K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Christopher MinarExecutive Officer, DirectorNamed in SEC Form D filings
  • Lonny StormoExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 4
  • PendingMethod And Device To Enhance Waste Clearance In The BrainUSPTOApplication 18486796
  • PendingMethod And Device To Enhance Waste Clearance In The BrainUSPTOApplication 17965747
  • PendingMethod And Device To Enhance Waste Clearance In The BrainUSPTOApplication PCTUS2023076840
Show all 4 patent records
  • Method And Device To Enhance Waste Clearance In The BrainFeb 15, 2024 · Application 18486796Pending
  • Method And Device To Enhance Waste Clearance In The BrainJul 27, 2023 · Application 17965747Pending
  • Method And Device To Enhance Waste Clearance In The BrainApplication PCTUS2023076840Pending
  • Method And Device To Enhance Waste Clearance In The BrainApplication 63302609Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .